Cas9

2016’s slow start for Initial Public Offerings (IPO) could be over, as four biotechs follow in the wake of several successful IPOs, most notably, BATS Global Markets, Inc. (BATS: BATS) and American Renal Associates Holdings Inc (NYSE: ARA). These stocks are up 25 and 26 percent, respectively...